Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium citrate for pediatric renal microlithiasis
IRCT20171030037093N40Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of potassium citrate in renal microlithiasis (RM) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Number of stones and Size of stones. Started Mar 2020; status: completed.
02
Drugs
potassium citrate
03
Conditions
renal microlithiasis (RM)
Beyond the preview
Go deeper on IRCT20171030037093N40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N40.